enovis.com - ENOV Profit before deduction of interest, taxes, depreciation and amortization
The EBITDA_Co trend demonstrates the financial dynamics of Enovis Corporation (ENOV), where the current value stands at 382.43. Business growth relies on mergers and acquisitions that optimize overall costs. The team brings together experts in biomechanics and robotics to improve human mobility. Global plants produce advanced rehabilitation and surgical solutions, ensuring stable demand for the products.
Summary analytical data breakdowns for Enovis Inc. (ENOV)
- stock value and consensus price forecast:
- issuer market value details:
- book capitalization indicators:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Enovis Corporation|ENOV - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio DJO Global|ENOV - Company Aggregate Debts|Debts to Book Value Enovis Corporation|ENOV - Company Long-Term Debts|Company Short-Term Indebtedness Enovis|Interim Coverage Ratio enovis.com
- earnings and market multiples details:
ENOV - Net Profit|Future Profit Enovis Corporation|ENOV - P/E Multiple|Forward P/E Multiple Enovis Corp|ENOV - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DJO Global|ENOV - Operating profit before deduction of amortization|Earnings per share for the trailing year Enovis|ENOV - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months enovis.com|ENOV - Earnings per share growth in current year|Net earnings per one share growth forecast for next year Enovis Corporation
- sales revenue and business income indicators:
Summary company analytics:Enovis Corporation
Enovis Corporation (ENOV) creates high switching costs for customers through an end-to-end cycle that integrates implants with software and rehabilitation. The company's adjusted EBITDA reflects the volume of real cash flow from these activities net of operating expenses. The trend in adjusted EBITDA allows for an assessment of the ecosystem's monetization efficiency under current market conditions. A contraction in this metric signals a risk of capital freeze, while steady growth confirms the market consensus regarding the viability of the business model.
Who Enovis Corporation competes with
BSX (Boston Scientific) - Profit before deduction of interest, taxes, depreciation and amortization|Edwards Lifesciences Corp - Operating profit EBITDA|Profit before interest, taxes and amortization ResMed|PODD: Operating profit EBITDA|Operating profit before amortization ZBH|Operating profit before deduction of amortization COO|Operating profit before amortization ALGN (Align Technology)|Operating profit before deduction of amortization GMED (Globus Medical)|TMDX (TransMedics Corp) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alphatec Corp ATEC|AORT - Operating profit before deduction of amortization|Integra LifeSciences Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Establishment Labs|BBNX: Operating profit EBITDA|Operating profit before amortization IRMD|EMBC (Embecta Health) - Operating profit EBITDA|Tandem Diabetes (TNDM) - Operating income before deduction of amortization|Operating profit EBITDA AXGN|Operating profit before deduction of amortization SI-BONE, Inc. SIBN|Operating profit EBITDA OFIX (orthofix.com)|Bioventus Corp - Profit before payment of interest, taxes and amortization|KIDS - Profit before payment of interest, taxes and amortization|TMCI: Profit before payment of interest, taxes and amortization|SRTA (Strata Critical Medical Inc) - Operating profit before deduction of amortization|Carlsmed Inc - Income before deduction of interest, taxes and amortization|RXST (RxSight Ophthalmic) - Operating profit EBITDA|Profit before interest, taxes and amortization clearpointneuro.com CLPT|Profit before payment of interest, taxes and amortization Stereotaxis Inc (STXS)|Neuronetics, Inc. (STIM) - Operating profit before depreciation charges|Sight Sciences Inc - Operating profit before deduction of amortization|Operating profit EBITDA Orchestra BioMed, Inc. OBIO|Anika Therapeutics Inc. - Operating profit EBITDA|Operating income before deduction of amortization InspireMD Inc NSPR|Jin Medical (ZJYL) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization VANI (Vivani)|Profit before payment of interest, taxes and amortization xtantmedical.com|Operating profit before deduction of amortization NeuroOne Medical Technologies (NMTC)|Operating profit EBITDA MODD|Myomo, Inc - Operating profit before amortization|Profit before payment of interest, taxes and amortization Envoy Medical, Inc. COCH|VVOS: Operating profit before amortization|NVNO: Operating profit before deduction of amortization|Sintx Technologies, Inc. - Company profit before taxes, interest and amortization|TNON (Tenon Medical, Inc.) - Operating profit before deduction of amortization|Lifeward - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization AMIX|Profit before payment of interest, taxes and amortization IVF|Profit before payment of interest, taxes and amortization Bone Biologics Corp (BBLG)|AXNX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization BIOLASE BIOL|Operating profit EBITDA dynatronics.com DYNT|FNA - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization INVO (invobioscience.com)
